Original InvestigationIntravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease
Under an Elsevier user license
open archive
Central Illustration
Key Words
calcification
coronary artery disease
optical coherence tomography
Abbreviations and Acronyms
DES
drug-eluting stent
FDA
U.S. Food and Drug Administration
IDE
investigational device exemption
IVL
intravascular lithotripsy
MACE
major adverse cardiovascular events
OCT
optical coherence tomography
PCI
percutaneous coronary intervention
PG
performance goal
Cited by (0)
Philippe Genereux, MD, served as Guest Associate Editor for this paper. Deepak L. Bhatt, MD, MPH, served as Guest Editor-in-Chief for this paper.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.
- ∗
Drs. Hill and Kereiakes contributed equally to this work.
© 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation